Inicio・Lista de Acciones・ResMed Inc

ResMed Inc

Cerrado

SectorSanidad

232.38 0.4

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

229.02

Máximo

233.16

Métricas clave
By Trading Economics
Ingresos	1.1B 1.5B
Ventas	32M 1.5B
P/B Media del Sector	21.5 57.371
BPA	2.95
Rentabilidad por dividendo	1.07
Margen de beneficios	104.075
Empleados	11,370
EBITDA	-91M 493M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+3.01% upside

Dividendos
By Acuity
Rentabilidad por dividendo Media del Sector	1.07% 2.23%
Próximas Ganancias	29 oct 2026
Fecha Próximo Dividendo	24 sept 2026
Próxima Fecha de Ex Dividendo	12 nov 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	574M 32B
Apertura anterior	231.98
Cierre anterior	232.38

Noticias sobre sentimiento de mercado

By Acuity

15%

85%

22 / 340 Clasificación en Healthcare

ResMed Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

21 ago 2026, 20:06 UTC

ResMed Inc shares are higher today, reflecting broader market trends. The stock remains above its 20-day moving average and near its one-month range.

20 ago 2026, 20:06 UTC

Shares of Resmed Inc. are lower amid rising crude oil prices and increasing U.S. Treasury yields, reflecting broader market trends. No specific company news was identified.

19 ago 2026, 20:02 UTC

Shares of Resmed Inc. are trading higher today, reflecting strong momentum and significant recovery from earlier session dips.

18 ago 2026, 19:41 UTC

News

ResMed Inc. plans a meeting with KeyBanc on August 26 in Montreal. Shares are trading higher since Monday's close, recovering from earlier fluctuations.

17 ago 2026, 20:06 UTC

News

ResMed Inc. shares are declining following a Q2 earnings report showing reduced operating margins and a $42 million charge related to safety actions.

14 ago 2026, 23:46 UTC

Resmed Inc. shares are lower in after-market hours amid broader market sentiment influenced by a surprising decline in U.S. retail sales for July.

13 ago 2026, 19:16 UTC

News

ResMed Inc reports Q2 revenue of $1.46 billion, matching estimates. Shares are higher amid investor sentiment despite challenges from rising costs and a safety charge.

12 ago 2026, 21:01 UTC

Resmed Inc. shares are trading lower in after-market hours, continuing a decline that began shortly after Wednesday's close. No specific news was identified.

11 ago 2026, 23:26 UTC

Resmed Inc. shares remained roughly flat in after-market hours, reflecting broader market conditions amid investor caution ahead of upcoming inflation data.

10 ago 2026, 20:02 UTC

Social Media

News

ResMed reported Q2 2026 sales of $1.46 billion, exceeding expectations. Shares are gaining today, despite earlier pulling back in the session.

8 ago 2026, 00:01 UTC

Resmed Inc. shares declined in after-market trading, moving below the 20-day moving average, despite earlier gains since Friday's close.

7 ago 2026, 23:41 UTC

News

ResMed shares declined after-market despite RBC Capital raising its price target to $244 and maintaining a Sector Perform rating.

6 ago 2026, 23:01 UTC

News

ResMed shares declined in after-market trading despite a fourth-quarter earnings beat. The company reported a non-GAAP EPS of $2.95 and revenue of $1.46 billion.

5 ago 2026, 19:11 UTC

News

ResMed Inc shares are higher as the company prepares for earnings on August 5, 2026, following a quarter that exceeded expectations.

4 ago 2026, 20:02 UTC

News

ResMed Inc shares are advancing, supported by strong cash flow and global growth. The stock has maintained a notable gain since Monday's close.

3 ago 2026, 21:02 UTC

News

ResMed Inc. shares are higher in after-market trading, supported by strong financials and a free cash flow margin of 31.7%.

31 jul 2026, 21:01 UTC

Resmed Inc shares advanced in after-market trading, significantly above their 20-day moving average. No specific news was identified to explain the increase.

30 jul 2026, 19:55 UTC

ResMed Inc's shares are declining today, diverging from a broader tech recovery. No specific news was identified to explain the move.

29 jul 2026, 19:04 UTC

ResMed Inc's shares are higher Wednesday, reflecting overall upward momentum since Tuesday's close, despite a recent pullback from session highs.

28 jul 2026, 19:02 UTC

Shares of Resmed Inc. are higher today, driven by gains in Health Care Equipment stocks. No specific news was identified to explain this increase.

27 jul 2026, 22:26 UTC

Resmed Inc shares are trading higher in after-hours activity, remaining above their 20-day moving average despite no specific news driving the price movement.

24 jul 2026, 16:03 UTC

ResMed Inc shares are higher today, driven by gains in the Health Care Equipment sub-sector, despite earlier volatility and recent underperformance.

22 jul 2026, 23:16 UTC

Resmed Inc shares are trading higher in after-market hours, rebounding from an initial dip and showing unusual strength compared to typical performance.

21 jul 2026, 20:56 UTC

Resmed Inc. shares are trading roughly flat after-market, amid broader market optimism following positive earnings from 3M and General Motors.

20 jul 2026, 19:16 UTC

ResMed Inc shares are lower today, continuing a downward trend since Friday. The stock briefly hit a session high earlier but has since declined.

Comparación entre iguales

Cambio de precio

ResMed Inc previsión

Precio Objetivo

By TipRanks

3.01% repunte

Estimación a 12 Meses

Media 238.5 USD 3.01%

Máximo 320 USD

Mínimo 213 USD

De acuerdo con 15 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para ResMed Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

15 ratings

Comprar

Mantener

Vender

De acuerdo con 15 analistas que ofrecen calificaciones bursátiles a para ResMed Inc Dist en los últimos 3 meses.

Sentimiento

By Acuity

22 / 340 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.